Detail Information of Genetic Polymorphisms
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0523 Transporter Info | ||||
| Gene Name | CACNG2 | ||||
| Protein Name | Voltage-dependent calcium channel gamma-2 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Genetic Polymorphisms of DT (GPD) | |||||
| Genetic Polymorphism | rs2284018 | ||||
| Site of GPD | chr22:36701519 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | C>G / C>T | ||||
| Minor Allele Frequency | T=0.2338/901 (Global) | ||||
| Genotype TT | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| Lithium | N.A. | Bipolar Disorder | Correlated with the decreased drug response in patients (compare with genotypes CC + CT) | [ 1] | |
| References | |||||
| 1 | Stargazin involvement with bipolar disorder and response to lithium treatment. Pharmacogenet Genomics. 2008 May;18(5):403-12. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.